Novavax (LTS:0UP6) Other Gross PPE : $472 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Novavax Other Gross PPE?

Novavax's Other Gross PPE for the quarter that ended in Mar. 2024 was $472 Mil.

Novavax's quarterly Other Gross PPE declined from Sep. 2023 ($492 Mil) to Dec. 2023 ($234 Mil) but then increased from Dec. 2023 ($234 Mil) to Mar. 2024 ($472 Mil).

Novavax's annual Other Gross PPE increased from Dec. 2021 ($50 Mil) to Dec. 2022 ($125 Mil) and increased from Dec. 2022 ($125 Mil) to Dec. 2023 ($234 Mil).

Novavax Other Gross PPE Historical Data

The historical data trend for Novavax's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novavax Other Gross PPE Chart

Novavax Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

9.09

9.68

50.41

125.14

233.53

Novavax Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															411.34	395.69	491.72	233.53	472.27

Novavax Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Novavax (LTS:0UP6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novavax Inc (LTS:0UP6) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

NVAX:USA NVAX:Mexico NVV1:Germany

Address

21 Firstfield Road, Gaithersburg, MD, USA, 20878

Website

https://www.novavax.com

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Novavax (LTS:0UP6) Headlines

No Headlines